Trials / Recruiting
RecruitingNCT04971577
Efficacy of Simvastatin in Alcoholic Liver Fibrosis
Efficacy of Simvastatin in Reducing Liver Fibrosis in Patients With Advanced Fibrosis Due to Alcohol: Randomized, Double-blind, Placebo-controlled Clinical Trial
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Anna Cruceta · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the efficacy of simvastatin in reducing liver fibrosis in patients with advanced fibrosis due to alcohol
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Simvastatin 40mg | participants will receive a capsule containing 4 tablets simvastatin 10 mg (40 mg total) every 24 hours at night |
Timeline
- Start date
- 2022-02-22
- Primary completion
- 2027-03-01
- Completion
- 2027-12-01
- First posted
- 2021-07-21
- Last updated
- 2024-12-04
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04971577. Inclusion in this directory is not an endorsement.